OraSure Technologies, Inc. has entered an agreement with Thermo Fisher Scientific to develop and supply as many as 12 homogenous fully automated oral fluid drugs of abuse assays for use with a new Intercept oral fluid specimen collection device. OraSure will have the right to purchase and resell the assays in the U.S. and certain other countries, subject to applicable regulatory approvals.   The companies anticipate selling NIDA-5 panel assays with the next generation Intercept device in the dom...